The short version
4 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Alvimopan
Alvimopan · ALVIMOPAN 12 mg/1 · Capsule · Oral · Hikma Pharmaceuticals USA Inc.
NDC 00054-0668-82 · 6 BLISTER PACK in 1 CARTON / 5 CAPSULE in 1 BLISTER PACK · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$4,975.14
Reported to Texas DSHS · 2026 annual filing · Hikma Pharmaceuticals USA Inc.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- West-Ward Columbus Inc.United Statesmanufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program · Alvimopan Shared System REMS Shared System REMS
Regulatory
- Application
- ANDA217753
- TE code
- AB
- Approval date
- Aug 31, 2023
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Alvimopan (Capsule)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Golden State Medical Supply, Inc. | ALVIMOPAN 12 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Hikma Pharmaceuticals USA Inc. | ALVIMOPAN 12 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Par Health USA, LLC | ALVIMOPAN 12 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Actavis Pharma, Inc. | ALVIMOPAN 12 mg/1 | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Alvimopan — NDC 00054-0668-82," retrieved September 3, 2026, https://drugdashboards.com/drug/00054066882.
Free to cite with attribution — see how the data is put together.